$5.02
-0.07-1.38%
Last update: Oct 23, 4:00 PM
Journey Medical Corp
DERMNASDAQ
Journey Medical (DERM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.02 | $-0.08 | $-0.05 | $-0.05 |
| Actual | $-0.01 | $-0.08 | $-0.04 | $-0.09 |
| Surprise | +50.0% | 0.00% | +20.0% | -80.0% |
| Revenue | ||||
| Estimate | $18.4M | $15.4M | $18.9M | $18.4M |
| Actual | $17.8M | $16.0M | $16.1M | $17.6M |
| Surprise | -3.24% | +3.67% | -15.1% | -4.14% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.01 | $0.03 | $0.08 | $0.15 |
| Revenue | ||||
| Consensus | $21.7M | $24.7M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.01 | $-0.02 | 50.0 % |
| Q1 | May 13, 2026 | $-0.08 | $-0.08 | 0.00 % |
| Q4 | Mar 25, 2026 | $-0.04 | $-0.05 | 20.0 % |
| Q3 | Nov 12, 2025 | $-0.09 | $-0.05 | -80.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $17.84M | $18.44M | -3.24 % |
| Q1 | May 13, 2026 | $15.96M | $15.40M | 3.67 % |
| Q4 | Mar 25, 2026 | $16.08M | $18.95M | -15.1 % |
| Q3 | Nov 12, 2025 | $17.63M | $18.39M | -4.14 % |
